Method for selecting patients for treatment with an egfr inhibitor

作者: Olli Carpen , Annika Algars , Minnamaija Lintunen , Jari Sundstrom , Raija Ristamaki

DOI:

关键词: PathologyCancerImmunohistochemistryEGFR inhibitorsInternal medicineOncologyTissue sectionsMedicineCancer cell

摘要: The present invention relates to cancer diagnostics and therapies the detection of alterations in cells that are diagnostic, prognostic or predictive. In particular, provides a method for detecting analyzing whether patient suffering from is responsive treatment with an EGFR inhibitor. method, tissue section sample subjected assays based on immunohistochemistry enzymatic metallography.

参考文章(207)
Philip Ross Hamann, Hwei-Ru Tsou, Nan Zhang, Bernard Dean Johnson, Allan Wissner, Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors ,(1998)
Fred R. Hirsch, Marileila Varella-Garcia, Rafal Dziadziuszko, Yun Xiao, Sujatha Gajapathy, Margaret Skokan, Ming Lin, Vincent O'Neill, Paul A. Bunn, Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer. Clinical Cancer Research. ,vol. 14, pp. 6317- 6323 ,(2008) , 10.1158/1078-0432.CCR-08-0539
Mauro Moroni, Silvio Veronese, Silvia Benvenuti, Giovanna Marrapese, Andrea Sartore-Bianchi, Federica Di Nicolantonio, Marcello Gambacorta, Salvatore Siena, Alberto Bardelli, Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study Lancet Oncology. ,vol. 6, pp. 279- 286 ,(2005) , 10.1016/S1470-2045(05)70102-9
Michelle D. Williams, Dianna B. Roberts, Merrill S. Kies, Li Mao, Randal S. Weber, Adel K. El-Naggar, Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance Clinical Cancer Research. ,vol. 16, pp. 2266- 2274 ,(2010) , 10.1158/1078-0432.CCR-09-0238
Pierre Laurent-Puig, Anne Cayre, Gilles Manceau, Emmanuel Buc, Jean-Baptiste Bachet, Thierry Lecomte, Philippe Rougier, Astrid Lievre, Bruno Landi, Valérie Boige, Michel Ducreux, Marc Ychou, Fréderic Bibeau, Olivier Bouché, Julia Reid, Steven Stone, Frédérique Penault-Llorca, Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer Journal of Clinical Oncology. ,vol. 27, pp. 5924- 5930 ,(2009) , 10.1200/JCO.2008.21.6796
Xiaoyan Wang, Shaobo Zhang, Gregory T. MacLennan, John N. Eble, Antonio Lopez-Beltran, Ximing J. Yang, Chong-Xian Pan, Honghong Zhou, Rodolfo Montironi, Liang Cheng, Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder Clinical Cancer Research. ,vol. 13, pp. 953- 957 ,(2007) , 10.1158/1078-0432.CCR-06-2167
Helena Linardou, Issa J Dahabreh, Dimitra Kanaloupiti, Fotios Siannis, Dimitrios Bafaloukos, Paris Kosmidis, Christos A Papadimitriou, Samuel Murray, Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer Lancet Oncology. ,vol. 9, pp. 962- 972 ,(2008) , 10.1016/S1470-2045(08)70206-7
M Taron, R Rosell, M Santarpia, E Felip, N Reguart, F Cecere, M Cuello, Usefulness of predictive tests for cancer treatment Bulletin Du Cancer. ,vol. 93, pp. 10101- 10108 ,(2006)